Immunomedics Inc. (IMMU) Dividend History

Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Last update 12/11/2018


Dividend Yield Summary

  2013 2014 2015 2016 2017 2018
Dividends - - - - - -
Average Price 4.52 4.07 3.34 2.92 8.48 20.22
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2018 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note
What other features would you like to see on this site? Please send us your comments: